By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vericel (Formerly Known As Aastrom Biosciences, Inc.) 

64 Sidney Sreet
P.O. Box 376
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-588-5555 Fax: 617-588-5554



Company News
Vericel (ASTM) Reports Second-Quarter 2017 Financial Results 8/9/2017 1:03:02 PM
Vericel (ASTM) To Host Second-Quarter 2017 Earnings Webcast And Conference Call On August 9, 2017 7/26/2017 9:54:16 AM
Vericel (ASTM) Reports First-Quarter 2017 Financial Results 5/10/2017 10:46:42 AM
Vericel (ASTM) Licenses Product Portfolio To Innovative Cellular Therapeutics For Distribution In China, South Korea, And Other Countries In Southeast Asia 5/10/2017 10:45:47 AM
Vericel (ASTM) To Host First-Quarter 2017 Earnings Webcast And Conference Call On May 10, 2017 5/5/2017 11:11:11 AM
Vericel (ASTM) Announces Appointment Of Michael Halpin As Senior Vice President, Quality And Regulatory Affairs 4/10/2017 9:10:18 AM
Vericel (ASTM) Rockets After the FDA Approves Its Maci Knee Implants 12/14/2016 9:26:29 AM
Vericel (ASTM)'s Stem Cell Heart Failure Therapy Cuts Deaths 4/5/2016 6:28:41 AM
Vericel (ASTM) Announces Publication Of Clinical Trial Rationale And Study Design For The Phase IIb Ixcell-DCM Trial Of Ixmyelocel-T In Patients With Heart Failure Due To Ischemic Dilated Cardiomyopathy 3/28/2016 7:44:29 AM
Vericel (ASTM) Reports Fourth-Quarter And Year-End 2015 Financial Results 3/14/2016 7:44:10 AM